About DRG International
DRG International is a company based in Springfield (United States) founded in 1970 was acquired by biocheckinc.com in August 2021. DRG International offers products and services including HYBRiD-XL Hepcidin 25, Salivary ELISA Kits, and CHROMagar.
- Headquarter Springfield, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Drg International Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
biocheckinc.com
(Aug 18, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DRG International
DRG International offers a comprehensive portfolio of products and services, including HYBRiD-XL Hepcidin 25, Salivary ELISA Kits, and CHROMagar.
ELISA kit for measuring bioactive Hepcidin levels in samples.
Non-invasive tests for detecting biomarkers in saliva samples.
Chromogenic media for single-step microbial identification.
Funding Insights of DRG International
Detailed funding history for DRG International
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DRG International
DRG International has secured backing from 1 investor. Prominent investors backing the company include biocheckinc.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
In-vitro diagnostic kits and research reagents are developed and marketed.
|
Locked | Locked | Locked |
Investor details for DRG International
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DRG International
Investment portfolio details for DRG International
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DRG International
Detailed financials for DRG International
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Drg International Comparisons
Peer comparison for DRG International
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DRG International
Detailed competitors of DRG International
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Drg International
Complete news archive for DRG International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DRG International
DRG International was founded in 1970.
DRG International is headquartered in Springfield, United States.
DRG International develops, manufactures and markets a variety of immunodiagnostic equipment and reagents. The company offers a complete range of diagnostic products and services in the field of cardiology and cardio-surgery products. The company offers a lab-top analyzer that has features of both an immunoassay analyzer and clinical chemistry analyzer, Single-step, chromogenic testing media for colorful microbial detection , and other lab equipment. In addition, the company offers ELISA kits for detection of FSH, Hepcidin, and new Saliva ELISA assays for DHEA, Cortisol, Estradiol, Testosterone, and Progesterone. The company offers its products in more than 110 countries.
DRG International offers HYBRiD-XL Hepcidin 25, Salivary ELISA Kits, and CHROMagar.
DRG International has 1 investor. Key investors include biocheckinc.com.